知识产权

港股IPO招股书披露先例 · 24 家公司,27 项

知识产权事项一般指专利、商标、版权等侵权诉讼及调查、权属或转让登记争议等纠纷。招股书通常在概要、风险因素、业务及财务资料章节披露诉讼进展、涉诉产品收入占比、已计提拨备及法律顾问或董事对重大性的评估;已和解的个案多说明和解安排、无侵权认定及收入合规情况,未决事项则辅以中止程序、计提拨备或完成权利登记等处理。

合规类事项自 2026 年 8 月 24 日起递交的文件开始收录。

2026-08-28Application Proof合规确认
维眸生物科技(浙江)股份有限公司VivaVision Biotech (Zhejiang) Co., Ltd.

核心产品FTO分析及不侵权确认

We have engaged our PRC IP Counsel and U.S. IP Counsel to carry out freedom-to-operate (FTO) analyses with respect to our Core Products.

Business · 第 212 页

Based on the FTO analyses, we were not aware of any issued patents that may affect our rights to conduct research and development or commercialization of our Core Products in China and the United States as of the Latest Practicable Date.

Business · 第 212 页

Directors are of the view that we have maintained sufficient intellectual property protection for our Core Products and product candidates, as well as their associated technologies, and had not infringed any third-party intellectual property rights during the Track Record Period and up to the Latest Practicable Date.

Business · 第 213 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-28Application Proof合规确认
南京诺令生物科技股份有限公司Nanjing Novlead Biotechnology Co., Ltd.

自由实施(FTO)分析及知识产权合规确认

Based on the freedom-to-operate (“FTO”) analysis, as of August 18, 2026, there is no substantial risk of infringement of valid and enforceable issued patents of any third party in the Chinese mainland, Europe and the U.S. that may impact the development and commercialization of our Core Product in the Chinese mainland, Europe and the U.S.

Business · 第 191 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-28Prospectus不合规事项
深圳麦科田生物医疗技术股份有限公司Medcaptain Medical Technology Co., Ltd.02041.HK

涉第三方实用专利侵权未决诉讼一宗

During the Track Record Period and up to the Latest Practicable Date, except for one pending lawsuit claiming our infringement of a third-party’s utility patent, which we believe is not material and the likelihood of the plaintiff proving infringement or securing any meaningful compensation against us as very low, we had not been involved in any proceedings in respect of, and we had not received notice of any claims alleging infringement of, any intellectual property rights, whether as claimant or a respondent, nor were we aware of any breach of the aforementioned confidentiality or non-compete obligations by the counterparties.

Business · 第 193 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-25Application Proof不合规事项
山东卓创资讯股份有限公司Sublime China Information Co., Ltd.

被诉不正当竞争及商标侵权已和解

In August 2020, Shanghai Nonferrous Network Information Technology Co., Ltd.* (上海有色網信息科技股份有限公司) (“Shanghai Nonferrous Network”) (as plaintiff), a PRC company with a registered capital of RMB12 million as at the Latest Practicable Date who is a comprehensive service provider in the non-ferrous metals industry, offering benchmark prices, analysis, information, and other services in the metals and mining sector, filed an alleged unfair competition and trademark infringement claim against our Company and our Shanghai branch.

Business · 第 167 页

However, taking into account that (1) as a commodity information service provider, we attach great importance to a healthy competitive relationship with companies in the same industry; (2) to avoid the possible prolonged court procedures; and (3) to reduce media attention, we opted for and undergone a mediation with the plaintiff under the direction of a judge on 20 May 2022 and have reached a settlement arrangement with the plaintiff at a settlement amount of approximately RMB4.0 million (the “Settlement Arrangement”).

Business · 第 167 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-25Application Proof不合规事项

在美国被诉外观专利侵权

The Plaintiff alleges that certain of our products marketed, imported, offered for sale, and sold in the U.S. market, for which we hold an authorized design patent, infringe a design patent owned by the Plaintiff (the “Asserted Patent”).

Risk Factors · 第 49 页

In 2026, the USPTO granted our request and instituted the ex parte reexamination proceeding with respect to the Asserted Patent.

Risk Factors · 第 49 页

As of the Latest Practicable Date, the litigation remained stayed.

Risk Factors · 第 49 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-24Prospectus不合规事项
希音国际控股有限公司SHEIN Global Holdings Limited00625.HK

逾40宗待决知识产权侵权诉讼

For example, we are currently involved in over 40 pending lawsuits that have been brought against us concerning alleged intellectual property rights infringement.

Risk Factors · 第 88 页

As of 31 March 2026, we had made provisions in the amount of approximately US$6.0 million for the over 40 pending IP lawsuits described above in accordance with IFRS.

Risk Factors · 第 88 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-24Prospectus不合规事项
希音国际控股有限公司SHEIN Global Holdings Limited00625.HK

与Temu在英国的知识产权诉讼及竞争反诉

In addition, we are involved in IP infringement lawsuits against Temu and their competition counterclaim against us in the UK.

Business · 第 207 页

In August 2026, the court issued a first-instance judgment, finding that whilst we owned the copyright in the vast majority of certain photographs used on Temu in 2023 and 2024, such use did not amount to copyright infringement under UK law at the time due to narrow technical reasons with respect to those specific photographs.

Business · 第 207 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看

Tell us